Narrative Review of the Advantages and Clinical Data to Support Evening Dosing for Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: A Prescriber Perspective

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder typically treated first-line with stimulants. This review provides guidance to prescribers by presenting an overview of available treatment options, along with clinical and real-world evidence for delayed-release and extended-release methylphenidate (DR/ER-MPH). Traditional long-acting stimulants differ in duration of effect, leading to gaps in symptom control during the afternoon and evening. DR/ER-MPH is a unique…

via https://pubmed.ncbi.nlm.nih.gov/42993109/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20261116041633&v=2.20.1


Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>